What Aura Biosciences, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 13 |
| Total trades | 5 | 32 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 425,399 | 2,179,726 |
| Disposed | 0 | 174,692 |
| Net activity | +425,399 | +2,005,034 |
Common stock only — 1 reported trade in the last 12 months is in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Person Julie | Chief People Officer | Sep 01 | Grant / award · A | +107,611 | — | — | 107,611 |
| Kratz Erica | Chief Reg. & Quality Officer | Sep 01 | Grant / award · A | +100,885 | — | — | 100,885 |
| Elazzouzi Amy | SVP, Finance & PAO | Sep 01 | Grant / award · A | +23,540 | — | — | 143,600 |
| Hopkins Janet Jill | Chief Medical Officer | Sep 01 | Grant / award · A | +58,850 | — | — | 380,190 |
| Abu-Absi Susan | Chief Operating Officer | Sep 01 | Grant / award · A | +134,513 | — | — | 134,513 |
| Bender Jeremy | Director | Jul 07 | Grant / award · A | +30,000 | — | — | 30,000 |
| Kilroy Conor | See Remarks | Jul 01 | Grant / award · A | +14,858 | — | — | 232,693 |
| Gibney Anthony S | See Remarks | Jun 16 | Open-market sale · S | −12,824 | $6.42 | −$82.3K | 265,354 |
| Johnson David Michael | Director | Jun 11 | Grant / award · A | +15,000 | — | — | 194,167 |
| Mattessich Antony C. | Director | Jun 11 | Grant / award · A | +15,000 | — | — | 38,500 |
| Bitetti Teresa Marie | Director | Jun 11 | Grant / award · A | +15,000 | — | — | 36,000 |
| Srivastava Sapna | Director | Jun 11 | Grant / award · A | +15,000 | — | — | 38,500 |
| Holles Natalie C. | See Remarks | May 19 | Grant / award · A | +553,844 | — | — | 1,153,962 |
| Holles Natalie C. | See Remarks | May 19 | Grant / award · A | +600,118 | — | — | 600,118 |
| Matrix Capital Management Company, Lp | 10% owner | May 07 | Open-market sale · S | −6,922,870 | $5.64 | −$39M | 0 |
| Kilroy Conor | See Remarks | Apr 16 | Open-market sale · S | −11,738 | $7.02 | −$82.4K | 217,835 |
| Elazzouzi Amy | Senior Vice President, Finance | Mar 02 | Grant / award · A | +44,528 | — | — | 120,060 |
| Kilroy Conor | See Remarks | Mar 02 | Grant / award · A | +62,339 | — | — | 229,573 |
| Hopkins Janet Jill | Chief Medical Officer | Mar 02 | Grant / award · A | +89,056 | — | — | 321,340 |
| Gibney Anthony S | See Remarks | Mar 02 | Grant / award · A | +71,245 | — | — | 278,178 |
Loading...
